Wall Street analysts’ outlook for Prothena Corporation plc (PRTA)

Prothena Corporation plc (NASDAQ: PRTA) stock jumped 0.11% on Monday to $52.52 against a previous-day closing price of $52.46. With 0.56 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.39 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $53.86 whereas the lowest price it dropped to was $50.46. The 52-week range on PRTA shows that it touched its highest point at $79.65 and its lowest point at $28.49 during that stretch. It currently has a 1-year price target of $93.44. Beta for the stock currently stands at 0.39.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PRTA was down-trending over the past week, with a drop of -3.54%, but this was down by -9.43% over a month. Three-month performance dropped to -23.25% while six-month performance rose 8.80%. The stock gained 75.07% in the past year, while it has lost -12.83% so far this year. A look at the trailing 12-month EPS for PRTA yields -2.77 with Next year EPS estimates of -4.09. For the next quarter, that number is -0.32. This implies an EPS growth rate of -278.70% for this year and -31.10% for next year. EPS is expected to decline by -0.60% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 9.60%.

Float and Shares Shorts:

At present, 53.12 million PRTA shares are outstanding with a float of 50.87 million shares on hand for trading. On Aug 30, 2023, short shares totaled 4.12 million, which was 7.69% higher than short shares on Jul 30, 2023. In addition to Dr. Gene G. Kinney Ph.D. as the firm’s Pres, CEO & Director, Mr. Tran B. Nguyen M.B.A. serves as its CFO & Chief Strategy Officer.

Institutional Ownership:

Other institutions hold 56.00% of PRTA, in contrast to 40.71% held by mutual funds. Shares owned by individuals account for 27.66%. As the largest shareholder in PRTA with 21.64% of the stake, EcoR1 Capital, LLC holds 11,584,280 shares worth 11,584,280. A second-largest stockholder of PRTA, Fidelity Management & Research Co, holds 7,912,583 shares, controlling over 14.78% of the firm’s shares. T. Rowe Price Associates, Inc. is the third largest shareholder in PRTA, holding 3,500,498 shares or 6.54% stake. With a 3.90% stake in PRTA, the Fidelity Growth Company Fund is the largest stakeholder. A total of 2,087,035 shares are owned by the mutual fund manager. The T Rowe Price New Horizons Fund, which owns about 3.09% of PRTA stock, is the second-largest Mutual Fund holder. It holds 1,656,122 shares valued at 87.48 million. Vanguard Health Care Fund holds 2.42% of the stake in PRTA, owning 1,293,898 shares worth 68.34 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, PRTA reported revenue of $1.31M and operating income of -$43.21M. The EBITDA in the recently reported quarter was -$41.55M and diluted EPS was -$0.88.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PRTA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With PRTA analysts setting a high price target of $129.00 and a low target of $60.00, the average target price over the next 12 months is $93.44. Based on these targets, PRTA could surge 145.62% to reach the target high and rise by 14.24% to reach the target low. Reaching the average price target will result in a growth of 77.91% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded PRTA stock several times over the past three months with 14 Buys and 31 Sells. In these transactions, 60,000 shares were bought while 60,000 shares were sold. The number of buy transactions has increased to 67 while that of sell transactions has risen to 167 over the past year. The total number of shares bought during that period was 739,465 while 739,465 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *